Evidence map›Paper›PMID 21404180›Full record

ReviewThe International journal of developmental biology2010

Structure and functions of powerful transactivators: VP16, MyoD and FoxA.

Hiroyuki Hirai, Tetsuya Tani, Nobuaki Kikyo

Open access · bronzeAbstract readReview
In one paragraph

Review in The International journal of developmental biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. The Antiviral Activity of Polyphenols.Molecular nutrition & food research · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Direct reprogramming as a route to cardiac repair.Seminars in cell & developmental biology · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Hiroyuki HiraiDepartment of Medicine, University of Minnesota, USA.
Tetsuya Tani
Nobuaki Kikyo
University of Minnesota · USKindai University · JP

Funding

Histone proline isomerization and gene regulationR01DK082430 · NIDDK · UNIVERSITY OF MINNESOTA · PI KIKYO, NOBUAKI · 2009 to 2010
$755k
NIDDK NIH HHS R01 DK082430
6 · The paper itself

Abstract

Induced pluripotent stem cell (iPSC) technology is a promising approach for converting one type of a differentiated cell into another type of differentiated cell through a pluripotent state as an intermediate step. Recent studies, however, indicate the possibility of directly converting one cell type to another without going through a pluripotent state. This direct reprogramming approach is dependent on a combination of highly potent transcription factors for cell-type conversion, presumably skipping more physiological and multi-step differentiation processes. A trial-and-error strategy is commonly used to screen many candidate transcription factors to identify the correct combination of factors. We speculate, however, that a better understanding of the functional mechanisms of exemplary transcriptional activators will facilitate the identification of novel factor combinations capable of direct reprogramming. The purpose of this review is to critically examine the literature on three highly potent transcriptional activators: the herpes virus protein, VP16; the master regulator of skeletal muscle differentiation, MyoD and the "pioneer" factor for hepatogenesis, FoxA. We discuss the roles of their functional protein domains, interacting partners and chromatin remodeling mechanisms during gene activation to understand how these factors open the chromatin of inactive genes and reset the transcriptional pattern during cell type conversion.

Indexed as

AnimalsCell DifferentiationHepatocyte Nuclear FactorsHerpes Simplex Virus Protein Vmw65HumansInduced Pluripotent Stem CellsMyoD ProteinTrans-ActivatorsHepatocyte Nuclear FactorsHerpes Simplex Virus Protein Vmw65MyoD ProteinTrans-Activators

Identifiers

PMID21404180
PMCPMC3419751
OpenAlexW2063207883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.